Solid Dispersion

Abstract Purpose: To develop aceclofenac hydrogel-based solid dispersions (AC-HSDs) encapsulated in two modified gelatin capsules (MGCs as MGX1 and MGX2)...

Abstract Amorphous solid dispersions (ASDs) make a significant contribution to enhancing the solubility of poorly soluble drugs. The incorporation of...

Abstract This study presents an innovative approach that utilizes polymers with different topologies and properties as potential matrices for the...

Abstract Lornoxicam (LOX) is (NSAID); it is a crystalline powder that ranges in color from orange to yellow and is...

Abstract Aceclofenac (ACF), a Non-Steroidal Anti-Inflammatory Drug (NSAID), is formulated with Soluplus® (SOLP) to enhance solubility and bioavailability. This study...

Abstract The incorporation of poorly soluble active ingredients, which make up the majority of the molecules in development, into fixed-dose...

Abstract The work involved taste masking of primaquine phosphate (PMQ), an intensely bitter drug used in the prevention and treatment...

Abstract The underlying mechanisms governing amorphous solid dispersions (ASDs) stability are complex and influenced by multiple factors, making it a...

Abstract Fast screening of amorphous solid dispersions (ASDs) is a need in the pharmaceutical industry. To support this, several emerging...

Abstract Sulpiride, (a model class IV drug) is a central dopamine antagonist, that is commonly used in the treatment of...